• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    MSC Industrial Direct, Radius Recycling And 3 Stocks To Watch Heading Into Tuesday

    7/2/24 2:29:42 AM ET
    $FLYE
    $MSM
    $RDUS
    $SLP
    Aerospace
    Industrials
    Industrial Machinery/Components
    Industrials
    Get the next $FLYE alert in real time by email

    With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

    • Wall Street expects MSC Industrial Direct Co., Inc. (NYSE:MSM) to report quarterly earnings at $1.50 per share on revenue of $1.01 million before the opening bell, according to data from Benzinga Pro. MSC Industrial Direct shares gained 1.1% to $79.10 in the after-hours trading session.
    • Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) named Peter Pfreundschuh as Chief Financial Officer, effective June 28. Y-mAbs Therapeutics shares fell 2.3% to $11.56 in the after-hours trading session.
    • Analysts are expecting Radius Recycling, Inc. (NASDAQ:RDUS) to post a quarterly loss at $0.66 per share on revenue of $693.90 million. The company will release earnings results before the markets open. Radius Recycling shares gained 4.6% to $15.99 in the after-hours trading session.

    Check out our premarket coverage here

    • Fly-E Group, Inc. (NASDAQ:FLYE) posted FY24 earnings of $0.9 per share, up from $0.6 per share in the year-ago period. The company's revenue rose to $32.2 million from $21.8 million. Fly-E Group shares fell 0.9% to $5.44 in the after-hours trading session.
    • Analysts expect Simulations Plus, Inc. (NASDAQ:SLP) to post quarterly earnings at $0.15 per share on revenue of $17.96 million after the closing bell. Simulations Plus shares gained 0.7% to $46.48 in after-hours trading.

    Check This Out: Wall Street’s Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields

    Get the next $FLYE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FLYE
    $MSM
    $RDUS
    $SLP

    CompanyDatePrice TargetRatingAnalyst
    MSC Industrial Direct Company Inc.
    $MSM
    2/6/2026$95.00Overweight → Neutral
    Analyst
    Simulations Plus Inc.
    $SLP
    12/18/2025Buy → Neutral
    BTIG Research
    MSC Industrial Direct Company Inc.
    $MSM
    10/8/2025Outperform → Peer Perform
    Wolfe Research
    Simulations Plus Inc.
    $SLP
    9/30/2025$16.00Hold
    TD Cowen
    Simulations Plus Inc.
    $SLP
    7/15/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    MSC Industrial Direct Company Inc.
    $MSM
    5/27/2025$89.00Neutral → Overweight
    Analyst
    Y-mAbs Therapeutics Inc.
    $YMAB
    4/22/2025$3.00Neutral → Underperform
    BofA Securities
    MSC Industrial Direct Company Inc.
    $MSM
    1/16/2025$95.00Outperform
    Wolfe Research
    More analyst ratings

    $FLYE
    $MSM
    $RDUS
    $SLP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Fly-E Group, Inc. Announces Receipt of Delinquency Notice from Nasdaq Regarding Delayed Form 10-Q

    NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- Fly-E Group, Inc. (NASDAQ:FLYE, the "Company")), an electric vehicle company engaged in designing, installing, selling and renting smart electric motorcycles, electric bikes, and electric scooters, announced today that on February 27, 2026, the Company received a written notice (the "Notice") from the Listing Qualifications staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it currently does not satisfy Listing Rule 5250(c)(1), as a result of not having timely filed with the U.S. Securities and Exchange Commission (the "Commission") its Form 10-Q for the period ended December 31, 2025 (the "Form 10-Q"). Th

    3/5/26 5:00:00 AM ET
    $FLYE
    Aerospace
    Industrials

    Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD

    Expert panel at the 2026 ASCPT Annual Meeting brings together leaders with industry and regulatory experience to explore practical, accountable AI implementation Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced a high-impact panel discussion, "From Debate to Deployment: Responsible, Practical AI in MIDD," to be held during the upcoming American Society for Clinical Pharmacology & Therapeutics (ASCPT) Annual Meeting on March 5, 2026 at 12:00 PM MST in Denver, CO. "There is no longer a question of whether artificial intelligence (AI) should be

    3/3/26 7:55:00 AM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations

    Extended projects support ongoing research into computational approaches and new approach methodologies for food and chemical safety assessment Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced the extension of two separate research collaborations with the U.S. Food and Drug Administration (FDA) and the National Institute of Environmental Health Sciences (NIEHS). The extended projects support ongoing federal research efforts focused on the development of new approach methodologies (NAMs) and advancing computational approaches for food and chemi

    2/9/26 6:45:00 PM ET
    $SLP
    EDP Services
    Technology

    $FLYE
    $MSM
    $RDUS
    $SLP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Jacobson Mitchell bought $1,943,037 worth of shares (22,870 units at $84.96), increasing direct ownership by 0.99% to 2,328,192 units (SEC Form 4)

    4 - MSC INDUSTRIAL DIRECT CO INC (0001003078) (Issuer)

    11/20/25 7:02:28 PM ET
    $MSM
    Industrial Machinery/Components
    Industrials

    Director Peller Philip bought $600,873 worth of shares (6,666 units at $90.14), increasing direct ownership by 232% to 9,537 units (SEC Form 4)

    4 - MSC INDUSTRIAL DIRECT CO INC (0001003078) (Issuer)

    11/17/25 10:00:15 AM ET
    $MSM
    Industrial Machinery/Components
    Industrials

    Director Jacobson Mitchell bought $15,408,432 worth of shares (181,806 units at $84.75), increasing direct ownership by 9% to 2,305,322 units (SEC Form 4)

    4 - MSC INDUSTRIAL DIRECT CO INC (0001003078) (Issuer)

    11/3/25 7:24:11 PM ET
    $MSM
    Industrial Machinery/Components
    Industrials

    $FLYE
    $MSM
    $RDUS
    $SLP
    SEC Filings

    View All

    $FLYE
    $MSM
    $RDUS
    $SLP
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    $FLYE
    $MSM
    $RDUS
    $SLP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $FLYE
    $MSM
    $RDUS
    $SLP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Fly-E Group Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits

    8-K - Fly-E Group, Inc. (0001975940) (Filer)

    3/5/26 5:00:27 PM ET
    $FLYE
    Aerospace
    Industrials

    MSC Industrial Direct Company Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - MSC INDUSTRIAL DIRECT CO INC (0001003078) (Filer)

    3/2/26 4:35:40 PM ET
    $MSM
    Industrial Machinery/Components
    Industrials

    Simulations Plus Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - Simulations Plus, Inc. (0001023459) (Filer)

    2/18/26 4:07:44 PM ET
    $SLP
    EDP Services
    Technology

    FDA Approval for DANYELZA issued to Y-MABS THERAPEUTICS INC

    Submission status for Y-MABS THERAPEUTICS INC's drug DANYELZA (SUPPL-8) with active ingredient NAXITAMAB-GQGK has changed to 'Approval' on 03/20/2024. Application Category: BLA, Application Number: 761171, Application Classification:

    3/21/24 10:20:07 AM ET
    $YMAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for TYMLOS issued to RADIUS HEALTH INC

    Submission status for RADIUS HEALTH INC's drug TYMLOS (SUPPL-13) with active ingredient ABALOPARATIDE has changed to 'Approval' on 12/19/2022. Application Category: NDA, Application Number: 208743, Application Classification: Efficacy

    12/21/22 4:37:57 AM ET
    $RDUS
    Industrial Specialties
    Consumer Discretionary

    FDA Approval for TYMLOS issued to RADIUS HEALTH INC

    Submission status for RADIUS HEALTH INC's drug TYMLOS (SUPPL-10) with active ingredient ABALOPARATIDE has changed to 'Approval' on 12/22/2021. Application Category: NDA, Application Number: 208743, Application Classification: Efficacy

    12/23/21 5:39:20 PM ET
    $RDUS
    Industrial Specialties
    Consumer Discretionary

    MSC Industrial downgraded by Analyst with a new price target

    Analyst downgraded MSC Industrial from Overweight to Neutral and set a new price target of $95.00

    2/6/26 8:09:59 AM ET
    $MSM
    Industrial Machinery/Components
    Industrials

    Simulations Plus downgraded by BTIG Research

    BTIG Research downgraded Simulations Plus from Buy to Neutral

    12/18/25 9:02:23 AM ET
    $SLP
    EDP Services
    Technology

    MSC Industrial downgraded by Wolfe Research

    Wolfe Research downgraded MSC Industrial from Outperform to Peer Perform

    10/8/25 8:24:33 AM ET
    $MSM
    Industrial Machinery/Components
    Industrials

    New insider Slone Reuben E claimed no ownership of stock in the company (SEC Form 3)

    3 - MSC INDUSTRIAL DIRECT CO INC (0001003078) (Issuer)

    3/2/26 4:49:48 PM ET
    $MSM
    Industrial Machinery/Components
    Industrials

    Chief Revenue Officer Dibella John Anthony Ii exercised 10,300 shares at a strike of $9.71, increasing direct ownership by 13% to 90,140 units (SEC Form 4)

    4 - Simulations Plus, Inc. (0001023459) (Issuer)

    2/9/26 4:08:21 PM ET
    $SLP
    EDP Services
    Technology

    Director Paladino Steven gifted 13,960 shares and received a gift of 13,960 shares, decreasing direct ownership by 90% to 1,568 units (SEC Form 4)

    4 - MSC INDUSTRIAL DIRECT CO INC (0001003078) (Issuer)

    2/5/26 3:45:06 PM ET
    $MSM
    Industrial Machinery/Components
    Industrials

    $FLYE
    $MSM
    $RDUS
    $SLP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Y-mAbs Therapeutics Inc.

    SC 13G/A - Y-mAbs Therapeutics, Inc. (0001722964) (Subject)

    11/14/24 4:32:10 PM ET
    $YMAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Radius Recycling Inc.

    SC 13G/A - RADIUS RECYCLING, INC. (0000912603) (Subject)

    11/14/24 12:27:50 PM ET
    $RDUS
    Industrial Specialties
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Y-mAbs Therapeutics Inc.

    SC 13G/A - Y-mAbs Therapeutics, Inc. (0001722964) (Subject)

    11/12/24 6:00:40 PM ET
    $YMAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FLYE
    $MSM
    $RDUS
    $SLP
    Leadership Updates

    Live Leadership Updates

    View All

    AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Sept. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 22, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space. Uber Technologies Inc. (NYSE:UBER) will replace Charter Communications Inc. (NASD: CHTR) in the S&P 100. Charter Communications will remain in the S&P 500.AppLovin Corp. (NASD: APP), Robinhood Markets Inc. (NASD: H

    9/5/25 6:34:00 PM ET
    $ACHC
    $APP
    $BGS
    Medical Specialities
    Health Care
    Computer Software: Programming Data Processing
    Technology

    MSC INDUSTRIAL SUPPLY CO. ANNOUNCES RESIGNATION OF CHIEF FINANCIAL OFFICER AND SEES FISCAL FOURTH QUARTER PERFORMANCE TRENDING TOWARDS THE UPPER HALF OF GUIDANCE RANGE

    MELVILLE, N.Y. and DAVIDSON, N.C., July 28, 2025 /PRNewswire/ -- MSC INDUSTRIAL SUPPLY CO. (NYSE:MSM) ("MSC," "MSC Industrial," the "Company," "we," "us," or "our"), a leading North American distributor of a broad range of metalworking and maintenance, repair and operations (MRO) products and services, today announced that Kristen Actis-Grande, Executive Vice President and Chief Financial Officer, has decided to step down from her position with MSC effective August 8, 2025 to become the Chief Financial Officer of a publicly traded company. Greg Clark, the Company's Vice Presid

    7/28/25 4:30:00 PM ET
    $MSM
    Industrial Machinery/Components
    Industrials

    Y-mAbs Appoints Experienced Commercial Leader as Head of DANYELZA Business Unit

    NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (NASDAQ:YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the treatment of cancer, today announced the appointment of Doug Gentilcore as Senior Vice President, Head of DANYELZA Business Unit. "I am pleased to welcome Doug to Y-mAbs as the new DANYELZA Business Unit head," said Michael Rossi, President and Chief Executive Officer. "We believe Doug's extensive experience leading pharmaceutical commercialization and operations on a global scale will be instrumental in our co

    1/10/25 7:35:00 AM ET
    $YMAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FLYE
    $MSM
    $RDUS
    $SLP
    Financials

    Live finance-specific insights

    View All

    Simulations Plus Reports First Quarter Fiscal 2026 Financial Results

    Investor Day on January 21, 2026, to present new product vision and AI solutions Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today reported financial results for its first quarter fiscal 2026, ended November 30, 2025. First Quarter 2026 Financial Highlights (as compared to first quarter 2025) Total revenue decreased 3% to $18.4 million Software revenue decreased 17% to $8.9 million, representing 48% of total revenue Services revenue increased 16% to $9.5 million, representing 52% of total revenue Gross profit was $10.9 million and gross mar

    1/8/26 4:05:00 PM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date

    Conference call to be on Thursday, January 8, 2026, at 5 p.m. ET Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus", "SLP"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced that it will report first quarter fiscal 2026 financial results after the market close on Thursday, January 8, 2026. Management will host a conference call that same day at 5:00 p.m. Eastern Time to discuss the results. Investment professionals and all current and prospective shareholders are invited to join the live webcast by registering here. The conference call can also be accessed by dialing 1-877-451-6152 (domestic) or 201-389-0879 (in

    12/17/25 7:50:00 AM ET
    $SLP
    EDP Services
    Technology

    Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results

    Reaffirms fiscal 2026 revenue guidance of $79 to $82 million and adjusted diluted EPS guidance of $1.03 to $1.10  Investor Day on January 21, 2026, to present new product vision and AI solutions Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in cheminformatics, biosimulation, clinical operations solutions and medical communications that accelerate biopharma innovation, today reported financial results for its fourth quarter and fiscal 2025, ended August 31, 2025. Fourth Quarter 2025 Financial Highlights (as compared to fourth quarter 2024) Total revenue decreased 6% to $17.5 million Software revenue decreased 9% to $9.0 million, representi

    12/1/25 4:05:00 PM ET
    $SLP
    EDP Services
    Technology